放射治疗计划CT上发现的偶发腋窝淋巴结肿大
本研究回顾性分析了2012至2022年间在放射治疗计划CT上发现可疑腋窝淋巴结、并由放疗科转诊至乳腺影像科的早期乳腺癌患者记录。共21例转诊,排除3例后纳入18例,其中15例(83%)超声显示异常淋巴结并建议活检(BI-RADS 4),这15例中3例(20%)活检证实肿瘤细胞阳性。淋巴结皮质增厚和中央脂肪门完全消失与病理性淋巴结相关。
要点
- 放疗计划CT发现可疑腋窝淋巴结的患者中,83%(15/18)超声显示异常并建议活检(BI-RADS 4)。
- 超声引导活检证实20%(3/15)为肿瘤细胞阳性,其中2例为原发系统治疗后未达病理完全缓解。
- 淋巴结皮质增厚和中央脂肪门完全消失与病理性淋巴结相关。
核心结论
- 超声区分反应性淋巴结与受累淋巴结的能力有限。
- 超声显示淋巴结皮质-门分界消失并结合临床特征,是可帮助指导是否需要进一步活检的参数。
- 组织病理学评估对于诊断残留腋窝病变很重要。
- 需要未来研究和指南来改善诊断能力并减少非受累淋巴结患者的活检数量。
研究设计与样本
- 回顾性研究,回顾2012至2022年以色列Sheba医学中心Meirav乳腺中心由放疗科转诊至乳腺影像科的所有乳腺癌患者病历。
- 仅进一步评估因放射治疗计划CT上见异常腋窝淋巴结而转诊的患者记录,研究期间共21例转诊,排除3例后纳入18例。
主要发现
- 18例纳入患者中15例(83%)超声显示异常淋巴结并建议超声引导活检(BI-RADS 4)。
- 15例中3例(20%)腋窝淋巴结活检肿瘤细胞阳性,其中2例为原发系统治疗后未达病理完全缓解的病例。
- 淋巴结皮质增厚和中央脂肪门完全消失与病理性淋巴结相关。
关键数值与推荐
- 超声异常淋巴结并建议活检的判定为BI-RADS 4。
- 皮质增厚和中央脂肪门完全消失被报告为与病理性淋巴结相关的特征。
临床怎么用
- 超声显示淋巴结皮质-门分界消失并结合临床特征,是可帮助指导是否需要进一步活检的参数。
- 组织病理学评估对于诊断残留腋窝病变很重要。
局限性
- 超声区分反应性淋巴结与受累淋巴结的能力有限。
- 需要未来研究和指南来改善诊断能力并减少非受累淋巴结患者的活检数量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate the rate of axillary node-positive disease in patients with early breast cancer who had a suspicious axillary lymph node on radiation planning computed tomography (CT). METHODS AND MATERIALS: A retrospective review was conducted of the medical records of all patients with breast cancer who were referred for axillary ultrasound from the radiation unit to the breast imaging unit at the Meirav Breast Center, Sheba Medical Center, from 2012 to 2022. Ethics approval was obtained. Only the records of patients who were referred due to an abnormal axillary lymph node seen on radiation planning CT were further evaluated. RESULTS: During the study period, a total of 21 patients were referred to the breast imaging unit for evaluation of suspicious nodes seen on radiation planning CT. Of these, 3 cases were excluded. A total of 15 out of the 18 (83%) patients included had an abnormal lymph node in the ultrasound, and an ultrasound-guided biopsy was recommended (BI-RADS 4). Of these, 3 (out of 15, 20%) had a positive biopsy for tumor cells from the axillary lymph node. Two were cases after primary systemic therapy without complete pathologic response. Thickening of the lymph node cortex and complete loss of the central fatty hilum were associated with pathologic lymph node. CONCLUSION: Sonar had limited ability to differentiate reactive nodes from involved nodes. The presence of lymph nodes with loss of cortical-hilum differentiation on ultrasound together with clinical features are parameters that can help guide the need of further biopsy. Histopathology evaluation is important to make the diagnosis of residual axillary disease. Future studies and guidelines are needed to improve the diagnostic abilities and reduce the number of patients who are undergoing biopsy for noninvolved nodes.
引用
- Faermann R, Sklair-Levy M, Shalmon A, et al. Incidental Axillary Lymphadenopathy Found on Radiation Planning Computed Tomography. Int J Radiat Oncol Biol Phys. 2024. PMID: 38401856. doi:10.1016/j.ijrobp.2024.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。